Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Armata Pharmaceuticals (ARMP) FCF Margin (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed FCF Margin for 6 consecutive years, with 1106.79% as the latest value for Q4 2018.

  • Quarterly FCF Margin rose 1304179.0% to 1106.79% in Q4 2018 from the year-ago period, while the trailing twelve-month figure was 1225.11% through Dec 2018, up 926859.0% year-over-year, with the annual reading at 225.1% for FY2025, 48306.0% down from the prior year.
  • FCF Margin hit 1106.79% in Q4 2018 for Armata Pharmaceuticals, up from 708.47% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 1106.79% in Q4 2018 to a low of 11935.0% in Q4 2017.
  • Historically, FCF Margin has averaged 4144.17% across 5 years, with a median of 2929.13% in 2016.
  • Biggest five-year swings in FCF Margin: surged 8151650bps in 2014 and later tumbled -906928bps in 2016.
  • Year by year, FCF Margin stood at 3173.27% in 2014, then skyrocketed by 42bps to 1849.22% in 2015, then tumbled by -271bps to 6868.18% in 2016, then plummeted by -74bps to 11935.0% in 2017, then soared by 109bps to 1106.79% in 2018.
  • Business Quant data shows FCF Margin for ARMP at 1106.79% in Q4 2018, 708.47% in Q3 2018, and 667.62% in Q2 2018.